Join the Vaccination and Prophlaxis group to help and get support from people like you.
Vaccination and Prophlaxis News (Page 4)
Vaccines Have Saved 154 Million Lives, Mostly Babies, Over Past 50 Years
MONDAY, April 29, 2024 – Global vaccination efforts have saved an estimated 154 million lives, including 101 million infants, a new study led by the World Health Organization (WHO) shows....
Most Moms-to-Be Interested in RSV Vaccination During Pregnancy
THURSDAY, April 25, 2024 – More than half of women who are pregnant or planning to become pregnant are very likely to get vaccinated against respiratory syncytial virus (RSV) during pregnancy,...
U.S. Measles Cases Reach 125, Surpassing Recent Peak in 2022
MONDAY, April 22, 2024 – Measles infections continue to spread across the country, with 125 cases now reported in 18 states, new U.S. government data shows. That is more cases than were reported in...
2011 to 2021 Saw Increase in Vaccination Timeliness for Infants
MONDAY, April 15, 2024 – From 2011 to 2021, there was an increase in vaccination timeliness among U.S. children aged 0 to 19 months, according to a study published online April 12 in JAMA Network...
'One and Done': Scientists Develop Vaccine That May Fight Any Viral Strain
TUESDAY, April 16, 2024 – Genetics-based “one-and-done” vaccines for the flu and COVID could prove more effective and easier to craft than current jabs, researchers report. These new vaccines would t...
Spike in Measles Cases Could Threaten Elimination Status in U.S.: CDC
FRIDAY, April 12, 2024 – More than 100 measles cases have already been reported in the United States this year, a significant increase over previous years that threatens the country's attempts to...
Chlamydia Vaccine Shows Promise in Early Trial
FRIDAY, April 12, 2024 – A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI)....
Adding Vaccine to Immunotherapy for Liver Cancer Shows Promise in Early Trial
TUESDAY, April 9, 2024 – A custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to shrink liver cancer as when a patient received immunotherapy alone, a new study...
Scientists Develop Vaccine Against Lethal Xylazine, Often Mixed With Street Drugs
MONDAY, April 8, 2024 (HealthDay news) – A new vaccine might be able to block the toxic effects of the animal tranquilizer xylazine, which is being added to illicit drugs and increasing overdose...
Vaccine-by-Mouth Could Replace Antibiotics in Fighting UTIs
MONDAY, April 8, 2024 – A new oral vaccine could prove a potential alternative to antibiotics for people with recurring urinary tract infections, a new study says. More than half of patients with...
Therapeutic Vaccine Prevents Pancreatic Cancer's Recurrence in 3-Year Trial
MONDAY, April 8, 2024 – A pancreatic cancer vaccine has continued to protect a small group of patients from their cancer coming back, three years after receiving the jab, a new study says. Eight...
Mpox Vaccine Protection Quickly Fades; Boosters Necessary: Study
MONDAY, April 1, 2024 – Vaccine protection against mpox fades quickly in the human immune system, even in people who’ve received the full two-dose regimen, a new real-world study shows. Antibody l...
Disparities Seen in HPV Vaccine Uptake Among U.S. Adults
FRIDAY, March 29, 2024 – There are sociodemographic disparities in human papillomavirus (HPV) vaccine uptake among 27- to 45-year-olds, according to a study published online March 28 in Human ...
ERs Might Be Good Spots to Offer Flu Shots
TUESDAY, March 26, 2024 — New research offers an easy prescription to get people to roll up their sleeves for a flu shot. Just ask them to. And then reinforce the invitation with a little video and p...
Annual Two-Dose SARS-CoV-2 Vaccination Campaign Beneficial
TUESDAY, March 26, 2024 – Annual administration of a second dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine five months after the initial dose results in fewer...
Ask a question
To post your own question to this support group, sign in or create an account.